Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters
Kit Wun Kathy Cheung, Bianca D. van Groen, Gilbert J. Burckart, et al.
The Journal of Clinical Pharmacology (2019) Vol. 59, Iss. S1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 147, pp. 105280-105280
Open Access | Times Cited: 219
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Zahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 289-331
Open Access | Times Cited: 114
Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
Laurens F. M. Verscheijden, Jan J. Koenderink, Trevor N. Johnson, et al.
Pharmacology & Therapeutics (2020) Vol. 211, pp. 107541-107541
Open Access | Times Cited: 124
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species
Bianca D. van Groen, Johan Nicolaï, A. C. Kuik, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 597-678
Open Access | Times Cited: 88
Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective
Xiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 3, pp. 501-526
Open Access | Times Cited: 40
Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development
Kefei Wang, Kun Jiang, Xiaoyi Wei, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 43
Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
Pavani Gonnabathula, Me-Kyoung Choi, Miao Li, et al.
Food and Chemical Toxicology (2024) Vol. 190, pp. 114789-114789
Closed Access | Times Cited: 6
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper
Anne Smits, Pieter Annaert, Giacomo Cavallaro, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 12, pp. 4965-4984
Open Access | Times Cited: 40
Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics
Jeffry Adiwidjaja, Alan V. Boddy, Andrew J. McLachlan
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 38
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
Laurens F. M. Verscheijden, Jan J. Koenderink, Saskia N. de Wildt, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 9, pp. 3015-3029
Open Access | Times Cited: 28
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics
Sara K. Quinney, Robert R. Bies, Shaun J. Grannis, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 5, pp. 391-402
Open Access | Times Cited: 11
A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept
Yuichi Sugiyama, Yasunori Aoki
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 9, pp. 1067-1076
Open Access | Times Cited: 11
Physiologically Based Pharmacokinetic Modeling to Refine Dosing of Posaconazole in Young Children
Paul R. V. Malik, Paola Mian
Clinical Therapeutics (2025)
Closed Access
A Pediatric Research Imperative: Addressing Neonates in Drug Development Through Understanding Neonatal Clinical Pharmacology
An N. Massaro, Elimika Pfuma Fletcher, Rajanikanth Madabushi, et al.
The Journal of Pediatric Pharmacology and Therapeutics (2025) Vol. 30, Iss. 1, pp. 8-16
Open Access
Pediatric off-label use and nonadherence management for nadolol: A mechanistic PBPK model Incorporating Ontogeny Scaling from Interracial Adults to Children
Xiang Chen, Guo Yu, Guangji Wang, et al.
Journal of Pharmaceutical Sciences (2025), pp. 103707-103707
Closed Access
Recent advances in the ontogeny of drug disposition
Brian D. Chapron, Alenka Chapron, J. Steven Leeder
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 10, pp. 4267-4284
Open Access | Times Cited: 26
Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care
Joyce E. M. van der Heijden, Jolien J. M. Freriksen, Marika A. de Hoop‐Sommen, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 12, pp. 1705-1717
Open Access | Times Cited: 16
Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism
Sandhya Subash, Dilip Kumar Singh, Deepak Ahire, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 6, pp. 2740-2750
Closed Access | Times Cited: 3
A close examination of BCRP's role in lactation and methods for predicting drug distribution into milk
Caroline Sychterz, Hong Shen, Yueping Zhang, et al.
CPT Pharmacometrics & Systems Pharmacology (2024)
Open Access | Times Cited: 3
Advancing understanding of human variability through toxicokinetic modeling, in vitro-in vivo extrapolation, and new approach methodologies
Anna Kreutz, Xiaoqing Chang, Helena T. Högberg, et al.
Human Genomics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport
Bianca D. van Groen, Karel Allegaert, Dick Tibboel, et al.
British Journal of Clinical Pharmacology (2020) Vol. 88, Iss. 10, pp. 4285-4296
Open Access | Times Cited: 27
Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children
Laurens F. M. Verscheijden, Carlijn H. C. Litjens, Jan J. Koenderink, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 3, pp. e1008786-e1008786
Open Access | Times Cited: 23
Pediatric Drug‐Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations
Daniel González, Jaydeep Sinha
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S1
Open Access | Times Cited: 22
Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study
Gopal Pawar, Fang Wu, Liang Zhao, et al.
The AAPS Journal (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 8
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
Jeffrey R. Strawn, Ethan A. Poweleit, Chakradhara Rao S. Uppugunduri, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top